|
KMID : 1191520170220010013
|
|
Journal of Korean Traditional Oncology
2017 Volume.22 No. 1 p.13 ~ p.22
|
|
|
A Case of Non-Small Cell Lung Carcinoma Patient Who Improved Skin Rash Due to Olmutinib by Administration of Nobongsangki-Jeong
|
|
Choi You-Na
Kim Jee-Hye
Bae Kyeo-Re
Cho Chong-Kwan
Yoo Hwa-Seung
|
|
|
Abstract
|
|
|
Objective: The purpose of this study is to report the effect of Nobongsangki-Jeong on skin rash caused by Olmutinib.
Methods: A female Non-Small cell lung carcinoma patient (Adenocarcinoma, Stage IV, Epidermal Growth Factor Receptor positive) suffered from skin rash due to the side effect of Olmutinib administration. She was treated with Nobongsangki-Jeong for the symptom management for 14 days. The clinical outcomes were measured by numeric rating scale (NRS) and National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 4.03.
Results: After treatment, skin rash was improved from NRS 5 to 1. Pruritus and pain of skin were improved from NCI-CTCAE grade 2 to 1.
Conclusion: This case study suggests that Nobongsangki-Jeong may have the efficacy for the treatment of skin rash caused by Olmutinib.
|
|
|
KEYWORD
|
|
|
Non-Small cell lung carcinoma, EGFR, Olmutinib, Skin Rash, Nobongsongki-jeong
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|